Today, the first study on the current status of cancer incidence and accessibility of health services in children and adolescents in my country was published in the journal The Lancet. This study was completed by Professor Ni Xin , a pediatric tumor research team of Professor Ni Xin , an affiliated to the Capital Medical University of the National Children's Medical Center, under the guidance and support of the National Health Commission. The founders of the research team are academicians of the Chinese Academy of Engineering Zhang Jinzhe and Hu Yamei .
Xinhua News Agency Data map
This study reports for the first time a comprehensive data on the latest incidence of cancer in children and adolescents in my country. The results show that from 2018 to 2020, a total of 121,145 children and adolescents were diagnosed with cancer in my country. The study also found that accessibility of health services, as one of the social determinants of health, plays an important role in the incidence of cancer in children and adolescents in my country; and further pointed out intervention measures to improve the current cancer status of children and adolescents in my country.
2018-2020 The average incidence of cancer in children and adolescents in my country was 126.48/million
As a long time ago, childhood cancer registration in my country has been included in the adult cancer registration work. Due to many factors in the number of childhood cancer cases and the limitations of registration methods, there has been a lack of high-quality and nationally representative data on cancer incidence in children and adolescents. In June 2019, the National Health Commission approved the establishment of the National Children's Hospital Affiliated to the Capital Medical University of the National Children's Medical Center to include the national children's cancer diagnosis and treatment institutions in the children's tumor monitoring network. As of September 2022, the children's tumor surveillance network has covered 587 children's tumor surveillance sites across the country, and 1.86 million childhood cancer cases have been registered.
Professor Ni Xin’s team deeply analyzed the monitoring data of the National Children’s Tumor Surveillance Network and the national related field database information, and estimated the cancer incidence of Chinese children (0-14 years old) and adolescents (15-19 years old) from January 1, 2018 to December 31, 2020. Based on the international classification standards for children’s tumors, the latest incidence rates of 12 major diagnostic groups, 47 subgroups and 81 cancer subtypes were reported.
The results of this study show that from 2018 to 2020, there were 40,380 new children and adolescent cancer patients each year; the three-year average total incidence was 126.48/million; the incidence of cancer in children aged 0-14 was 122.86/million, and the incidence of cancer in adolescents aged 15-19 was 137.64/million. Among children, the top three cancers are leukemia (42.33/million), central nervous system tumor (19.59/million), and lymphoma (11.54/million); among adolescents, malignant epithelial cancer and melanoma rank first (30.39/million), followed by leukemia (30.08/million) and central nervous system tumor (16.75/million).
It is worth noting that the local data report of before this made many industry insiders believe that new leukemia patients account for 50% or even higher proportion of childhood tumors. However, the results of this research prove that leukemia accounts for about 32%, lymphoma accounts for about 9.7%, and nearly 60% of patients are solid tumor patients, indicating that the epidemiological burden of epidemiology of children's solid tumors is even underestimated.
Source: CCTV News Client
Process Editor: TF016
